Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Medivera Compounding Pharmacy
483
•Medivera Compounding Pharmacy•November 13, 2014

Medivera Compounding Pharmacy – FDA 483, Nov 13, 2014

Record Details

This FDA Form 483 document outlines several deficiencies observed during an inspection, primarily concerning the manufacturing of sterile drug products. The facility's operations are cited for not having established procedures to prevent microbiological contamination of sterile drug products.

Personnel clothing is deemed inappropriate for their duties in drug product processing. The aseptic processing areas are deficient in two key aspects: the system for monitoring environmental conditions and the systems for maintaining equipment used to control aseptic conditions.

Furthermore, the document notes the absence of a written testing program to assess the stability characteristics of drug products. Container closure systems are found to be inadequate, failing to provide sufficient protection against foreseeable external factors that could lead to deterioration or contamination. Finally, each batch of drug product purporting to be sterile and pyrogen-free is not laboratory tested to confirm conformance to these requirements. These observations indicate significant issues within the facility's quality system and manufacturing controls for sterile products.

Company
Medivera Compounding Pharmacy
Inspection date
November 13, 2014
Product type
Drugs
Office
Detroit District Office
People
  • Emily J. Orban
  • Sarah M. Napier (Investigator )
View Company Profile

ID · ba737f08-9870-44a5-b506-fc426365d693

Other documents for Medivera Compounding Pharmacy
  • 483 - 2017-06-19June 19, 2017
  • STATE_REFERRAL_LETTER - 2017-06-05June 5, 2017
  • 483_RESPONSE - 2014-11-13November 13, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Medivera Compounding Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.